CAZILA CANDE CANDE GLOCAND ADVANTEC ADVANT ADVANT BLOPRESS BLOPRESS PROSARTAN PROSARTAN PROSARTAN PROSARTAN-DU SKYGEN NEO SKYGEN NEO SKYGEN NEO SKYGEN NEO CARAC-H CARAC CARAC CARAC CANDITENSIN CANDITENSIN CANDITENSIN CANREC CANREC CANREC PLUS CANREC PLUS TREATAN D TREATAN TREATAN TREATAN CANSAAR PLUS CANSAAR CANSAAR CANSAAR CANDERA CANDERA CANAXIT QUARTZ QUARTZ QUARTZ QUARTZ KANDO KANDO KANDO KANDO DIASTOLIC DIASTOLIC H ENADIL ENADIL CANDES 3H CANDES 3H CANDES 3H CANDES 3H CANDTRAN CANDTRAN CARTEX CARTEX CARTEX-H KANDI KANDI KANDI ATASART ATASART NIXETIL NIXETIL RAYSARTAN RAYSARTAN RAYCAN-H

Dose: 8 mg
Single Dose: 8 (8)
Frequency: 24 hourly
Route: PO
Instructions: Adjusted a/c to response. Max. 16 mg once daily.

Candesartan Cilexetil is the derivative of Candesartan. It is of Synthetic origin. .

Candesartan is contraindicated in conditions like Cholestasis,Pregnancy,Breast feeding.

The symptomatic adverse reactions produced by Candesartan are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Myalgia, Abdominal pain, Rashes, Arthralgia, Influenza like syndrome, Respiratory tract infections, Back pain.

Candesartan is primarily indicated in conditions like Hypertension, and can also be given in adjunctive therapy as an alternative drug of choice in Diabetic nephropathy, Heart failure.

Candesartan is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementDiazoxideEnhanced hypotensive effect when Diazoxide given with Candesartan. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tabs Store in a well closed container, at room temperature, . Protect from Sunlight, Moisture and Heat.

Hepatic and renal impairment; use with caution in renal artery stenosis, aortic or mitral valve stenosis and in obstructive hypertrophic cardiomyopathy.Monitor plasma-potassium concentration, particularly in elderly and in patients with renal impairment; lower initial doses may be appropriate in these patients.